Global Human Liver Model Market Report 2022: Emerging 3D and 2D Trends in Modeling Human Liver Disease in Vitro Fuel Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Human Liver Model Market Research Report by Product (2D Models, 3D Bio Printing, and Liver Organoids), Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Human Liver Model Market size was estimated at … [Read more…]

Coastal Medical Transportation Systems Announces Agreement to Expand Ambulance Network

Transformative Healthcare Deal Poised to Make a Substantial and Immediate Impact Within the Regional Medical Transportation Landscape HYANNIS, Mass.–(BUSINESS WIRE)–Coastal Medical Transportation Systems (CMTS), a privately owned and operated medical transportation company dedicated to providing the highest quality of care with compassion, dignity and respect for customers and their patients, and Transformative Healthcare, today announced … [Read more…]

Applied DNA’s Biotherapeutics Subsidiary Publishes Manuscript Demonstrating that a LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial in Ferrets

– Promising Results Support Further Development of LinearDNA as a Next Generation Vaccine Platform – STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN #LinearDNA—Applied DNA Sciences, Inc. (NASDAQ: APDN) (‘Applied DNA’ or the “Company”), a leader in polymerase chain reaction (PCR”)-based technologies, today announced the publication of a manuscript, co-authored with international academic and industry scientists, containing data demonstrating … [Read more…]

Sickle Cell Disease Association of America & Partners Launch New PSA to Boost Awareness and Understanding of the Disease

The “Believe it!” Campaign Will be Featured on TV Networks and Radio Stations Across the U.S., Driving Viewers to SCDBelieveIT.org HANOVER, MD and WATERTOWN, Mass.–(BUSINESS WIRE)–The Sickle Cell Disease Association of America, Inc. (SCDAA), in partnership with Forma Therapeutics, Inc. (Nasdaq: FMTX) today announced that they have joined forces to create a public service announcement … [Read more…]

The Worldwide Smart Pulse Oximeters Industry is Expected to Reach $3.4 Billion by 2031 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Smart Pulse Oximeters Market By Type, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering. The smart pulse oximeters market was valued at $1,639.19 million in 2021 and is expected to reach $3,453.29 million by 2031, growing at a CAGR of 7.7% from 2022 to … [Read more…]

Global Companion Diagnostics Market 2022-2028: Ongoing Research and Investments in Next Generation Gene-Sequencing Presents Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Companion Diagnostics Market 2022-2028” report has been added to ResearchAndMarkets.com’s offering. Market Outlook Based on this report, the global companion diagnostics market is projected to progress with a CAGR of 12.84% during the forecast period 2022-2028. The prominent factors fueling the global market’s growth include a surge in medication reaction incidence, increasing … [Read more…]

Navidea Biopharmaceuticals Appoints Joshua Wilson to the Board of Directors; Announces Dates Related to its 2022 Annual Meeting of Stockholders

DUBLIN, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced the appointment of Joshua (“Josh”) Wilson to its Board of Directors, effective September 30, 2022, with a term ending concurrently with the Company’s 2024 annual stockholders’ meeting. Mr. Wilson … [Read more…]

EnPlusOne Biosciences Launches Enzymatic RNA Synthesis Platform with $12 Million in Seed Financing

RNA synthesis platform to target synthesis lengths greater than 100-nt, large-scale GMP manufacturing, and novel therapeutic modifications in collaboration with industry partners Advanced-stage technology with over six years of development at the Wyss Institute at Harvard University, co-founded by Dr. George Church of Harvard Medical School, and the first spin-out from the Northpond Labs Alliance … [Read more…]

Teva Reaches Agreement With Georgia to Settle the State’s Price Fixing Claims

TEL AVIV, Israel & PARSIPPANY, N.J.–(BUSINESS WIRE)–Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), has reached an agreement with the Attorney General (AG) of Georgia to settle the state’s price-fixing claims against Teva. Teva will pay the state $3.346 million as part of the settlement, and the state will … [Read more…]

Global Immunotherapy Market Research and Forecast, 2022-2028: Featuring AstraZeneca, Gilead, Novartis, Merck & Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Immunotherapy Market Research and Forecast, 2022-2028” report has been added to ResearchAndMarkets.com’s offering. The global immunotherapy market is growing at a CAGR of 13.8% during the forecast period (2021-2027). The major factors that are augmenting the growth of the immunotherapy market includes increasing prevalence of auto-immune diseases among adults and increasing investments … [Read more…]